Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C

Published:2016-01-14 Issue:7 Volume:51 Page:733-740
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Suda Goki,Kudo Mineo,Nagasaka Atsushi,Furuya Ken,Yamamoto Yoshiya,Kobayashi Tomoe,Shinada Keisuke,Tateyama Miki,Konno Jun,Tsukuda Yoko,Yamasaki Kazushi,Kimura Megumi,Umemura Machiko,Izumi Takaaki,Tsunematsu Seiji,Sato Fumiyuki,Terashita Katsumi,Nakai Masato,Horimoto Hiromasa,Sho Takuya,Natsuizaka Mitsuteru,Morikawa Kenichi,Ogawa Koji,Sakamoto Naoya

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-016-1162-8.pdf

Reference28 articles.

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333–42.

2. Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002;36(5 Suppl 1):S35–46.

3. Iwasa Y, Otsubo S, Sugi O, Sato K, Asamiya Y, Eguchi A, et al. Patterns in the prevalence of hepatitis C virus infection at the start of hemodialysis in Japan. Clin Exp Nephrol. 2008;12(1):53–7.

4. Bergman S, Accortt N, Turner A, Glaze J. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis. 2005;45(4):684–9.

5. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Miller LG, Daar ES, Gjertson DW, et al. Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol. 2007;18(5):1584–93.

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis;Frontiers in Public Health;2023-09-29

3. Current elimination status of hepatitis C virus‐infected maintenance hemodialysis patients in Iwate Prefecture, Japan;Therapeutic Apheresis and Dialysis;2023-05

4. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02

5. Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma;Cancers;2023-01-18